Provided by Tiger Trade Technology Pte. Ltd.

DiaMedica Therapeutics Inc.

6.53
+0.01430.22%
Volume:55.51K
Turnover:359.33K
Market Cap:352.08M
PE:-9.13
High:6.57
Open:6.53
Low:6.32
Close:6.52
52wk High:10.42
52wk Low:5.14
Shares:53.88M
Float Shares:28.20M
Volume Ratio:0.57
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7157
EPS(LYR):-0.7000
ROE:-114.62%
ROA:-64.12%
PB:9.18
PE(LYR):-9.33

Loading ...

DiaMedica Therapeutics Says Trial of DM199 to Treat Acute Ischemic Stroke Reaches 75% Enrollment

MT Newswires Live
·
May 20

DiaMedica ReMEDy2 stroke trial hits 75% enrollment milestone for interim analysis

Reuters
·
May 20

DiaMedica Therapeutics Announces 75% Enrollment Milestone in Remedy2 Phase 2/3 Acute Ischemic Stroke Trial

THOMSON REUTERS
·
May 20

DiaMedica Therapeutics CEO joins RBC Global Healthcare Conference fireside chat

Reuters
·
May 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 08

H.C. Wainwright Keeps Their Buy Rating on Diamedica Therapeutics (DMAC)

TIPRANKS
·
May 08

DiaMedica Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

DiaMedica Q1 net, operating income miss estimates; R&D costs to rise moderately

Reuters
·
May 07

DiaMedica Q1 FY26 net loss widens to $10 million

Reuters
·
May 07

DiaMedica Therapeutics Inc - Reports $51.3 Mln in Cash and Investments, Runway Through 2027

THOMSON REUTERS
·
May 07

DiaMedica Therapeutics Q1 Cash & Investments USD 51.3 Million

THOMSON REUTERS
·
May 07

DiaMedica Therapeutics Inc - Remedy2 Phase 2/3 Trial Interim Analysis Planned Q4 2026

THOMSON REUTERS
·
May 07

DiaMedica Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
May 05

Press Release: DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026

Dow Jones
·
Apr 30

DiaMedica Therapeutics updates financial calendar with upcoming quarterly results call

Reuters
·
Apr 30

Companies Like DiaMedica Therapeutics (NASDAQ:DMAC) Are In A Position To Invest In Growth

Simply Wall St.
·
Apr 18

DiaMedica Therapeutics publishes 2025 annual report, sees cash runway through 2027

Reuters
·
Apr 02

DiaMedica Therapeutics announces annual shareholder meeting notice and proxy statement

Reuters
·
Apr 02

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Diamedica Therapeutics (DMAC), Elevance Health (ELV) and Oric Pharmaceuticals (ORIC)

TIPRANKS
·
Apr 01

DiaMedica Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 31